Genomic assays enhance risk assessment by providing detailed insights into the molecular pathways affected by toxicants. This information allows for a more accurate prediction of adverse effects, enabling regulatory agencies and industries to make informed decisions about the safety of chemicals and products. By integrating genomic data with traditional toxicological endpoints, a more holistic understanding of toxicity can be achieved.
